ELIQUIS .5 mg/1 (Apixaban TABLET, FOR SUSPENSION) .5 mg/1

ELIQUIS .5 mg/1 is an oral medication containing apixaban, used to manage blood clotting conditions. This tablet suspension is designed for convenient administration, offering a practical solution for those requiring anticoagulant therapy.

Strength

.5 mg/1

Pack Size

28 PACKET in 1 CARTON (0003-1028-12) / 4 TABLET, FOR SUSPENSION in 1 PACKET

Manufacturer / TM Owner

E.R. Squibb & Sons, L.L.C.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ELIQUIS .5 mg/1 is primarily used to reduce the risk of blood clots in conditions like atrial fibrillation. It is also employed to treat deep vein thrombosis and pulmonary embolism, helping to prevent further clotting. The medication is often prescribed for individuals who need long-term management of these conditions.

Side Effects

Common effects of ELIQUIS .5 mg/1 may include mild bleeding, bruising, and gastrointestinal discomfort. Some users might experience dizziness or fatigue. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

ELIQUIS .5 mg/1 should be handled with care to avoid excessive bleeding. It is important to follow the prescribed dosage and administration instructions. Patients with a history of bleeding disorders or those taking other blood-thinning medications should use this product under medical supervision.

Avoid Interactions

ELIQUIS .5 mg/1 may interact with other medications, including blood thinners, NSAIDs, and certain antibiotics. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

ELIQUIS .5 mg/1 is used to manage blood clotting conditions, such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism.

ELIQUIS .5 mg/1 is an oral medication available as a tablet for suspension, designed for easy administration.

Common side effects may include mild bleeding, bruising, and gastrointestinal discomfort.

ELIQUIS .5 mg/1 may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

ELIQUIS .5 mg/1 is often prescribed for long-term management of blood clotting conditions, but it should be used under medical supervision.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.